Latest Naloxone Stories
SOUTH SAN FRANCISCO, Calif., March 30 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction.
SAN DIEGO, Oct. 27 /PRNewswire-FirstCall/ -- Data from a phase II study demonstrated that oral NKTR-118 improved lower gastrointestinal dysfunction by increasing the frequency of bowel movements in patients with opioid-induced constipation, while simultaneously preserving opioid-mediated analgesia.
Scientists at Georgia State University have uncovered the mechanisms of how pain in infancy alters how the brain processes pain in adulthood.
Discovery of way to balance effects of two drugs sets stage for safer pain relief.
LONDON and SAN CARLOS, Calif., Sept.
SAN ANTONIO and SAN CARLOS, Calif., Sept.
For years, placebos have been given as a medical alternative to falsely reinforce a patientâ€™s expectations of feeling better. New research shows this dummy medicine may serve a higher purpose.
Exercise is always being advised for good health but a study in rats found extreme exercise may be physically addicting, U.S.
Although exercise is good for your health, extreme exercise may be physically addicting. Rats given a drug that produces withdrawal in heroin addicts went into withdrawal after running excessively in exercise wheels, according to new research. Rats that ran the hardest had the most severe withdrawal symptoms.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.